Clinical Trial Update: Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. [Phase 3]

View source ↗

Summary

Phase 3 trial updating on the prevention of recurrent thrombosis with Xarelto compared to no treatment in patients with chronic portal vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Portal Vein Thrombosis

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Deep Vein Thrombosis, Chronic Portal Vein Thrombosis | Phase 3 | Status: COMPLETED